Evidence map›Paper›PMID 31971144›Full record

ArticleThe American journal of tropical medicine and hygiene2020

A Roadmap for the Development of Ivermectin as a Complementary Malaria Vector Control Tool.

The Ivermectin Roadmappers, Peter Billingsley, Fred Binka, Carlos Chaccour, Brian Foy, Silvia Gold, Matiana Gonzalez-Silva, Julie Jacobson, George Jagoe, Caroline Jones and 20 more

Open access · hybridAbstract readConsensus Statement
In one paragraph

Article in The American journal of tropical medicine and hygiene, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 61 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
61citing papers in PubMed, 3 pooled it
14.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

61 citing papers in PubMed, 3 syntheses or guidelines pooled it, 115 citations in OpenAlex.

  1. Pooled it
  2. Ivermectin treatment in humans for reducing malaria transmission.The Cochrane database of systematic reviews · 2021
    Pooled it
  3. Pooled it
  4. Trial
  5. Trial
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. Efficacy of ivermectin and its metabolites againstAntimicrobial agents and chemotherapy · 2024
    Article
  20. Article

1 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 1 institution in 1 country.

The Ivermectin RoadmappersFull List of Contributors in the Acknowledgments.
Peter BillingsleySanaria, Inc.
Fred BinkaUniversity of Health and Allied Sciences
Carlos ChaccourISGlobal
Brian FoyColorado State University
Silvia GoldFundación Mundo Sano
Matiana Gonzalez-SilvaISGlobal
Julie JacobsonBridges to Development
George JagoeMedicines for Malaria Venture
Caroline JonesKEMRI Wellcome Trust Research Programme
Patrick KachurColumbia University
Kevin KobylinskiArmed Forces Research Institute of Medical Sciences
Anna LastLondon School of Hygiene and Tropical Medicine
James V LaveryEmory University
David MabeyLondon School of Hygiene and Tropical Medicine
David MboeraSACIDS Foundation for One Health
Charles MbogoKEMRI Wellcome Trust Research Programme
Ana Mendez-LopezISGlobal
N. Regina RabinovichISGlobal
Sarah ReesInnovative Vector Control Consortium
Frank RichardsThe Carter Center
Cassidy RistVirginia-Maryland College of Veterinary Medicine at Virginia Tech
Jessica RockwoodInternational Public Health Advisors
Paula Ruiz-CastilloISGlobal
Jetsumon SattabongkotMahidol University
Francisco SauteCentro de Investigação em Saúde da Manhiça
Hannah SlaterPATH
Andrew SteerUniversity of Melbourne
Kang XiaSchool of Plant and Environmental Sciences, Virginia Tech
Rose ZullingerUS President’s Malaria Initiative/US Centers for Disease Control and Prevention
Sanaria · US

Funding

Medical Research Council MR/P023843/1Medical Research Council MR/S005013/1Wellcome Trust
6 · The paper itself

Abstract

In the context of stalling progress against malaria, resistance of mosquitoes to insecticides, and residual transmission, mass drug administration (MDA) of ivermectin, an endectocide used for neglected tropical diseases (NTDs), has emerged as a promising complementary vector control method. Ivermectin reduces the life span of

Indexed as

AfricaAnimalsAntiparasitic AgentsEndemic DiseasesHumansInsecticidesIvermectinLethal Dose 50MalariaMass Drug AdministrationMosquito VectorsSafetySpainWorld Health OrganizationAntiparasitic AgentsInsecticidesIvermectin

Identifiers

PMID31971144
PMCPMC7008306
OpenAlexW3007577090

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.